18 March 2021: Clinical Research
Atosiban Combined with Ritodrine for Late Threatened Abortion or Threatened Premature Labor Patients with No Response to Ritodrine: A Clinical Trial
Shuai Fu 1ABC* , Haitian Xie 1DEF* , Yilei Zhong 12BCD* , Qi Xu 1D , Liqiong Zhu 1B , Hanjie Mo 1B , Jianping Zhang 1AG , Yinglin Liu 1CF , Hui Chen 1AG , Yonghong Zhong 2AD* , Jianping Tan 1AD*DOI: 10.12659/MSM.929743
Med Sci Monit 2021; 27:e929743
Table 2 Indicators of infection before treatment. Categorical data are shown as a frequency (percentage) and continuous data are shown as mean±SD. The t test was used for analyzing quantitative data, and the χ2 test was used for analyzing categorical data. P<0.05 was considered statistically significant.
| Items | Control group (n=22) | Research group (n=30) | P | OR (95%CI) |
|---|---|---|---|---|
| White blood cell counts (×10/L) | 10.20±3.75 | 11.45±2.07 | 0.133 | – |
| Neutrophils (%) | 70.85±9.4 | 78.81±6.58 | 0.001* | – |
| C-reactive protein (mg/L) | 6.23±6.61 | 16.19±20.28 | 0.016 | – |
| Leucorrhea cleanliness | 1.93±0.39 | 2.02±0.68 | 0.733 | – |
| Monilial infection (cases) | 3 | 5 | 0.779 | 1.27 (0.27–5.97) |
| Mycoplasma infection (cases) | 7 | 8 | 0.264 | 0.78 (0.23–2.61) |
| * | ||||